These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26611894)

  • 1. Acute Onset of Anemia After IV Immunoglobulin.
    Gradidge E; Rodwig F; Warrier R
    Clin Pediatr (Phila); 2016 Jun; 55(6):572-3. PubMed ID: 26611894
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute hemolysis secondary to high-dose intravenous immunoglobulin in a patient with Stevens-Johnson syndrome.
    Shakouri AA; Bahna SL
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):463-4. PubMed ID: 22626604
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe hemolytic anemia following high-dose intravenous immunoglobulin administration in a patient with Kawasaki disease.
    Nakagawa M; Watanabe N; Okuno M; Kondo M; Okagawa H; Taga T
    Am J Hematol; 2000 Mar; 63(3):160-1. PubMed ID: 10679809
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemolytic anemia following intravenous immunoglobulin administration.
    Yin F; Nesbitt JA; Tobian AA; Holt PA; Mikdashi J
    Am J Hematol; 2008 Oct; 83(10):825. PubMed ID: 18756544
    [No Abstract]   [Full Text] [Related]  

  • 5. Massive intravascular haemolysis after high dose intravenous immunoglobulin therapy.
    Mohamed M; Bates G; Eastley B
    Br J Haematol; 2013 Mar; 160(5):570. PubMed ID: 23294261
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemolytic anaemia associated with high dose intravenous immunoglobulin therapy in a child with Guillain-Barré syndrome.
    Trifa M; Simon L; Hamza J; Bavoux F; des Roziers NB
    Arch Dis Child; 2003 Sep; 88(9):836-7. PubMed ID: 12937119
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoglobulin high-dose therapy: RBC-alloantibodies in commercial preparations and haemolytic anaemia: a case report.
    Kluge A; Dopfer R; Pfeiffer-Wolf I; Roelcke D
    Beitr Infusionsther Transfusionsmed; 1994; 32():474-5. PubMed ID: 9422126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.
    Alioglu B; Avci Z; Ozyurek E; Ozbek N
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):636-9. PubMed ID: 17805040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side-effects of intravenous immune globulins.
    Duhem C; Dicato MA; Ries F
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis in the setting of systemic lupus erythematosus.
    Konda S; Fernandez AP; Berman B; Elgart G; Milikowski C; Alonso-Llamazares J
    Int J Dermatol; 2011 Oct; 50(10):1270-5. PubMed ID: 21950295
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute renal dysfunction caused by nonsucrose intravenous immunoglobulin in common variable immunodeficiency.
    Kim AS; Broide DH
    Ann Allergy Asthma Immunol; 2017 Feb; 118(2):231-233. PubMed ID: 28024991
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous immunoglobulin-induced hemolytic anemia in a patient with juvenile dermatomyositis.
    Clemenz MR; McGowan Iv JW; Shuler MJ; Lynn AW
    J Drugs Dermatol; 2013 Jan; 12(1):111-3. PubMed ID: 23377338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insisting on intravenous polyvalent immunoglobulin therapy in polymyositis in spite of the occurrence of sever hemolytic anemia].
    Ballot-Brossier C; Mortelecque R; Sinègre M; Marceau A; Dauriat G; Courtois F
    Transfus Clin Biol; 2001 Apr; 8(2):94-9. PubMed ID: 11386046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
    Markvardsen LH; Christiansen I; Harbo T; Jakobsen J
    Eur J Neurol; 2014; 21(1):147-52. PubMed ID: 24180709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome.
    Chamouni P; Tamion F; Gueit I; Girault C; Lenain P; Varin R; Czernichow P
    Transfus Apher Sci; 2003 Apr; 28(2):117-24. PubMed ID: 12679114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hemolytic anemia complicating infectious mononucleosis: the mechanism of hemolysis.
    Deaton JG; Skaggs H; Levin WC
    Tex Rep Biol Med; 1967; 25(3):309-17. PubMed ID: 4294303
    [No Abstract]   [Full Text] [Related]  

  • 17. Variable Clinical Presentations of ABO Incompatibility in Dizygotic Twins.
    Mundy CA; Bhatia J
    Neonatal Netw; 2015; 34(6):317-9. PubMed ID: 26803011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential approaches to prevent uncommon hemolytic side effects of AB0 antibodies in plasma derivatives.
    Buchta C; Macher M; Höcker P
    Biologicals; 2005 Mar; 33(1):41-8. PubMed ID: 15713555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycoplasma pneumoniae infection associated with hemolytic anemia--report of one case.
    Wang JL; Ho MY; Shen EY
    Acta Paediatr Taiwan; 2004; 45(5):293-5. PubMed ID: 15868814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin-induced hemolytic anemia after thoracoscopic thymectomy for myasthenia gravis.
    Tsukada H; Sunkara R; Chi DD; Keogh D; Gaissert H
    Ann Thorac Surg; 2014 Jun; 97(6):2175-7. PubMed ID: 24882299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.